First-Line Tx of HER2+ Metastatic BC: Could Investigational Approaches Improve on Current SOC?

Experts in oncology discuss investigational approaches for first-line treatment of HER2-positive metastatic breast cancer. For the complete activity, including supporting material, please visit: www.peervoice.com/GNV861. Presented by: Cristina Saura Manich, MD, PhD, and Aditya Bardia, MD. Learning Objectives: Evaluate the clinical data for emerging therapeutic strategies for the management of HER2+ metastatic breast cancer in the first-line setting; Discuss key learnings from clinical trials for investigative first-line treatment approaches for HER2+ metastatic breast cancer in context of different patient and disease characteristics.